drugset / Trial / NCT06529445

Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects

NCT06529445 ↗

Phase 1 Completed 84 enrolled Jiangsu vcare pharmaceutical technology co., LTD
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate Food effect and Relative bioavailability of VC004 Capsules in healthy subjects

Timeline

Start
2024-07-22
Primary completion
2024-08-26
Completion
2024-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject VC004 Unknown — —